Previous Article | Next Article ![]()
Journal of Virology, February 2006, p. 1592-1598, Vol. 80, No. 3
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.3.1592-1598.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Michael L. Farrell,1,
Laurie T. Krug,1
Jason W. Upton,1,2 and
Samuel H. Speck1*
Center for Emerging Infectious Diseases, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, Georgia 30329,1 Graduate Program in Molecular Cell Biology, Washington University School of Medicine, St. Louis, Missouri 631102
Received 8 July 2005/ Accepted 2 November 2005
The gammaherpesvirus immediate-early genes are critical regulators of virus replication and reactivation from latency. Rta, encoded by gene 50, serves as the major transactivator of the lytic program and is highly conserved among all the gammaherpesviruses, including Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and murine gammaherpesvirus 68 (
HV68). Introduction of a translation stop codon in
HV68 gene 50 (gene 50.stop
HV68) demonstrated that Rta is essential for virus replication in vitro. To investigate the role that virus replication plays in the establishment and maintenance of latency, we infected mice with gene 50.stop
HV68. Notably, the gene 50.stop virus established a long-term infection in lung B cells following intranasal infection of mice but was unable to establish latency in the spleen. This complete block in the establishment of latency in the spleen was also seen when lytic virus production was inhibited by treating mice infected with wild-type virus with the antiviral drug cidofovir, implicating virus replication and not an independent function of Rta in the establishment of splenic latency. Furthermore, we showed that gene 50.stop
HV68 was unable to prime the immune system and was unable to protect against a challenge with wild-type
HV68, despite its ability to chronically infect lung B cells. These data indicate gammaherpesviruses that are unable to undergo lytic replication in vivo may not be viable vaccine candidates despite the detection of cells harboring viral genome at late times postinfection.
J.M.M. and M.L.F. contributed equally to this work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»